| Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts S Faict, J Muller, K De Veirman, E De Bruyne, K Maes, L Vrancken, ... Blood cancer journal 8 (11), 105, 2018 | 137 | 2018 |
| Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? D Kegyes, C Constantinescu, L Vrancken, L Rasche, C Gregoire, B Tigu, ... Journal of Hematology & Oncology 15 (1), 78, 2022 | 26 | 2022 |
| In vitro Th17-polarized human CD4+ T cells exacerbate xenogeneic graft-versus-host disease L Delens, G Ehx, J Somja, L Vrancken, L Belle, L Seidel, C Grégoire, ... Biology of Blood and Marrow Transplantation 25 (2), 204-215, 2019 | 24 | 2019 |
| Radiotheranostic agents in hematological malignancies J Caers, E Duray, L Vrancken, G Marcion, V Bocuzzi, K De Veirman, ... Frontiers in Immunology 13, 911080, 2022 | 5 | 2022 |
| What is new in the management of multiple myeloma L Vrancken, J Muller, M Lejeune, C Gregoire, L Delens, A Jaspers, ... Revue Medicale Suisse 14 (615), 1438-1442, 2018 | 2 | 2018 |
| What is new in MGUS and smoldering multiple myeloma M Vercruyssen, L Vrancken, J CAERS Belgian Journal of Hematology 9, 2018 | 1 | 2018 |
| Multiple myeloma: an overview of advances in biology and treatment L Vrancken, M Lejeune, M Pirotte, E Duray, M Köse, Y Beguin, J Caers Revue Medicale de Liege 76 (5-6), 482-487, 2021 | | 2021 |
| Impact of Th17 cells on xenogeneic graft-versus-host disease L Delens, S Servais, G Ehx, L Vrancken, G Fransolet, C Gregoire, ... BONE MARROW TRANSPLANTATION 52, S194-S194, 2017 | | 2017 |
| Th17 cells impact on xenogeneic graft-versus-host disease L Delens, S SERVAIS, G Ehx, L Vrancken, G Fransolet, C GREGOIRE, ... 2017 Immunology day FNRS-Immunology Doctoral School, 2017 | | 2017 |
| Impact of Th17 population on xenogeneic graft-versus-host disease L Delens, S SERVAIS, L Vrancken, G Ehx, G Fransolet, M Hannon, ... 32nd General Annual Meeting of the Belgian Hematology Society, 2017 | | 2017 |
| Focus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention L Vrancken, L Delens, Y Beguin, F Baron, S Servais Onco: Revue Multidisciplinaire d'Oncologie 11, 2017 | | 2017 |
| Xenogeneic graft-versus-host disease: Impact of Th17 cells. L Delens, S SERVAIS, L Vrancken, G Ehx, G Fransolet, M Hannon, ... Journée des chercheurs Télévie 2017, 2016 | | 2016 |
| Impact des cellules Th17 sur la GVH xénogénique L Delens, S SERVAIS, G Ehx, L Vrancken, G Fransolet, C GREGOIRE, ... 16ème édition du congrès de la SFGM-TC, Société Francophone de Greffe de …, 2016 | | 2016 |
| Th17 cell population seems to aggravate xenogeneic graft-versus-host disease L Delens, Y BEGUIN, L Vrancken, G Ehx, G Fransolet, M Hannon, ... 2016 Immunology day FNRS-Immunology Doctoral School, 2016 | | 2016 |
| Salt but not glucocorticoïds enhances Th17 differentiation from naïve T cells in vitro L Delens, S SERVAIS, L Vrancken, G Ehx, G Fransolet, M Hannon, ... 31st General Annual Meeting of the Belgian Hematological Society, 2016 | | 2016 |
| Revisiting Th17 cell subsets in the setting of allogeneic stem cell transplantation and (cortico-refractory) graft-versus-host disease L Delens, S Servais, M Hannon, G Ehx, G Fransolet, S DUBOIS, C Daulne, ... Journée Télévie 2016, 2015 | | 2015 |
